MONTREAL, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”...
MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”...
Record Q4 and year-end total revenues of $23.4 million and $82.2 million, representing a 28% and 43% increase...
MONTREAL, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE...
Gross cannabis revenues before excise taxes increased to $26.2 million in Q3 2024 from $20.6 million in Q3...
Cannara Biotech Reports Q2 2024 Financial Results Canada NewsWire MONTREAL, April 29, 2024 Net revenue...
Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion Canada...
Cannara Biotech annonce l'engagement d'Independent Trading Group (ITG) pour la prestation de services...
Cannara Biotech Announces Notice Of Annual General Meeting Of Shareholders To Be Held Virtually On January...
Cannara Biotech to Host Investor Webcast on Thursday December 14th, 2023 Canada NewsWire MONTREAL, Dec. 11...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads